5 August 2026
Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.
1 July 2026
Ebola treatment trials in the DRC need at least $18m in urgent funding to test experimental drugs and strengthen contact tracing.
26 March 2026
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.
17 March 2026
Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.
7 January 2026
South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.
24 November 2025
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
5 September 2025
Gilead’s Lenacapavir is set to revolutionise HIV prevention efforts, aiming to protect two million people across affected nations.
29 June 2025
Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.